Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors. Miyashita Y, Tajima K, Izumi K, Matsumoto N, et al. Cancer Sci 2025;116:1392-1404.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Miyashita Y, Tajima K, Izumi K, Matsumoto N, et al. Novel Approach to Overcome Osimertinib Resistance Using Bromodomain and Extra-Terminal Domain Inhibitors. Cancer Sci 2025;116:1392-1404.
PMID: 40036147